Emerging Pathogens Flashcards

1
Q

Define emerging infectious diseases.

A

Infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range or caused by one of NIAID category A,B,C priority pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define opportunistic infections.

A

Infections occurring due to bacteria, fungi, viruses or parasites that normally do not cause a disease but become pathogenic when body’s defense system is impaired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are 3 reasons for pathogens emerging?

A

Development of new diagnostic tools
Increase in human exposure to bacterial pathogens
Emergence of more virulent bacterial strains & opportunistic infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is ‘one health’?

A

Integrated, unifying approach to balance & optimize the health of people, animals & environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are 4 examples of disease control & prevention?

A

Vaccination
Environmental sanitation
Vector control
Reduction of population growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How are pathogens detected in pts?

A

Culture based
Microscopic examination
Molecular methods (PCR/NGS/MS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 3 conventional techniques for environment screening?

A

Multiple tube fermentation
Membrane filters
Microscopic examination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are 3 advanced techniques for environment screening?

A

Immunological methods (ELISA)
Molecular methods (PCR/FISH)
Enzymatic methods
Emerging methods (biosensors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is MALDI-TOF MS?

A

Matrix assisted laser desorption ionization-time of flight MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is MS?

A

Analytical approach that measures the mass-to-charge ration of compounds & calculates its exact molecular weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are 5 advantages of MALDI-TOF MS?

A

Fast diagnosis
Avoiding unnecessary antimicrobial use
Reduced morbidities & costs
Based on intact proteins
Low cost of analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 3 disadvantages of MALDI-TOF MS?

A

Trained laboratory personnel
Identification of new species relies strongly on complete database
Initial investment in expensive equipment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are 6 characteristics of healthcare-associated-infections?

A

Unusual epidemiology & transmission
Medical environment
New infection sources & transmission ways
Another underlying disease
Strains emerging from microbiome
Subspecies level identification needed to define outbreaks & transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 3 examples of HAI?

A

MRSA
VRE
Multi-drug resistant E. Coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What 4 pathogens are in the critical group of WHO bacterial priority pathogens?

A

Enterobacterales carbapenem - resistant
Enterobacterales 3rd gen cephalosporin resistant
Acinetobacter baumanii
Mycobacterium Tb rifampicin resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 2 characteristics of emerging respiratory tract pathogens?

A

Most common opportunistic pathogens in nosocomial infections
Developing a high level of Ab resistance that involves multiple mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the ESKAPE emerging respiratory tract pathogens?

A

Enterococcus faecium
Staphylococcus aureus
Klebsiella pneumoniae
Acinetobacter baumannii
Pseudomonas aeruginosa
Enterobacter spp.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What can MALDI-TOF MS be used for?

A

Identifying resistance
Growth of bacteria directly on MALDI-TOF MS target (4-5h)
Identification of spectra directly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What type of bacteria are emerging CF pathogens?

A

Opportunistic
Commensal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are 6 emerging CF pathogens?

A

MRSA - easy transmission
Nontuberculous mycobacteria - ubiquitous environmental organisms eg. M. abscessus complex
Achromobacter spp. - environmental, rare opportunistic eg. A. ruhlandii
Stenotrophomonas maltophilia - aquatic environmental reservoirs
Pandoraea spp.
E.coli - no transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are 7 characteristics of Mycobacterium abscessus?

A

Non-TB
Rapidly growing
Environmental (soil, water, animals, free living amoeba)
Opportunistic - concern in immunocompromised people
Increasing prevalence
Intrinsic & acquired resistance
IC proliferation & survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What was M. abscessus historically considered as?

A

Environmental contaminant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are 6 adaptations of M. abscessus?

A

Opportunity to colonise host
Adaptation to host environment -> pre-adaptation in amoeba & metabolic switch, genetics & acquirement of virulence factors
Developing transmission routes
Drug resistance
Niche specialisation
Dormancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What 2 ways does M. abscessus spread?

A

Transformation in true pathogen
Inter-human transfer (direct/environmental)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What 2 pieces of evidence leads to evolution towards a pathogen?

A

Proof of person-to-person transmission
Proof of incidence in individuals with no known underlying conditions

26
Q

What 3 things need to happen to lead to evolution towards a pathogen?

A

Pre-adaptation in environment
Intrinsic resistance to many Abs
Co-colonisation with other species of opportunistic bacteria (acquire new VFs)

27
Q

What are 4 non-mycobacterial VFs?

A

Phospholipase C
MgtC
MsrA
ABC Fe(3+) transporters

28
Q

What pathogen is the pharma industry becoming interested in?

A

Non-TB Mycobacteria

29
Q

What is an example of an opportunistic pathogen?

A

Enterococcus spp

30
Q

What are 3 sources of E. spp?

A

Gut colonization 7-10 days after birth
Adulthood sources - certain food
Environment - colonization of biotic & abiotic substances

31
Q

What 4 infections can lead to pathogenic E. spp (mutagenic effects at sites of infection?

A

UTI
sepsis
ulcers
catheter related

32
Q

What happens in dysbiosis of E. spp?

A

Enterococcal overgrowth in epithelial cell -> biofilm -> virulent

33
Q

What are 5 commensal roles of E. spp?

A

Immune homeostasis
Produce bacteriocins against pathogens
Role in digestion
Block spread of putrefactive bacteria
Lower cholesterol levels

34
Q

What are 5 sources of E. spp in probiotics?

A

Biotherapeutics for chronic sinusitis
Bio-preservatives
Dietary supplementation for animals
Starter cultures in dairy products
After antibiotics

35
Q

When does E. spp become pathogenic?

A

Nosocomial infections
VF & resistance factors transmitted between species or genera by horizontal gene transfer
Food spoilage
Food poisioning

36
Q

What are 6 therapy examples for emerging bacterial diseases?

A

Silver NPs
Antimicrobial light therapy
Antimicrobial peptides
Abs
Vaccines
Bacteriophage therapy

37
Q

What are 4 characteristics of AMPs?

A

Short, +vely charged, amphiphilic, diverse

38
Q

What are AMPs?

A

Host defense oligopeptides produced by all organisms

39
Q

What are 2 factors of AMPs MoA?

A

broad spectrum of activity
interact with cell membrane - cell lysis

40
Q

What are 8 mechanisms of synergy between AMPs & Abs?

A

Promoting bacterial absorption of Abs
Change membrane permeability
Interference with bacterial cell membrane
Target LPS in gram -ve bacteria
Destabilize LPS structure
Inhibit metabolic pathways
Inhibit drug resistant enzymes
Block efflux pumps

41
Q

What are 6 AMPs advantages?

A

Unlikely to induce resistance
Broad range of action
Rapid bactericidal activity
Target poly-microbial infections
Improve action of Abs
Easy availability

42
Q

What are 3 cons of AMPs?

A

Potentially toxic
Unstable in presence of proteases
Expensive to make

43
Q

What are 4 light sources for ALT?

A

Xenon lamps
Light emitting diodes
Laser beams
Fiber optics

44
Q

What type of wave length are preferred in ALT?

A

Longer - deeper tissue penetration

45
Q

How does ALT work?

A

uses a photosensitizer (PS)—a light-activated compound—combined with a specific light source to generate reactive oxygen species (ROS)

46
Q

What 5 things does ROS do to the bacterial cell?

A

Cell membrane disruption
Interrupted transmembrane electron transport
Damage to proteins
DNA damage
Damage to ribosomes

47
Q

What are 5 characteristics of an ideal PS?

A

Strong absorption peak
Substantial triplet quantum yield
High tissue selectivity
No toxicity to human cells
High stability

48
Q

What are 4 natural PSs?

A

Curcumin
Chlorophyll
Riboflavin
Chlorins

49
Q

What are 5 advantages of ALT?

A

Broad spectrum of action
No resistance after multiple sessions
Used to support Ab therapy
Non-invasive
Low cost

50
Q

What are 3 cons of ALT?

A

Sub-optimal uptake of PS by bacteria
Lack of selectivity
Short light penetration depths

51
Q

How do silver NPs work?

A

Act by releasing Ag+ ions
Less reactive than silver ions

52
Q

What are silver NPs action dependent on?

A

Physical, chemical, thermal, electrical & optical properties
(shape, size, concentration)

53
Q

What do colloidal forms of AgNPs show?

A

Enhanced antimicrobial potential

54
Q

What 4 ways are colloidal AgNPs synthesized by?

A

Chemical reduction
Physical
Biological
Green methods

55
Q

What 4 things do the released Ag+ ions do?

A

Generate ROS
Disrupt electron transport & signal transduction pathways
Disrupt cell wall, cell membrane, cellular DNA & proteins
Inhibit planktonic cells & biofilms

56
Q

What are 3 safety concerns of silver NPs?

A

Ag comparatively non- toxic/mutagenic compared to other metals
Resistance against AgNPs
Influence on microbiome

57
Q

What 3 things can AgNPs do to cells?

A

Carcinogenesis & fibrosis
Genotoxicty
Cytotoxicty

58
Q

What have AgNPs been used for?

A

Prevention on infection
CF inhalation therapy
M. TB, M. bovis & multiple drug resistant TB strains

59
Q

What are 4 potentials of AI for emerging pathogens?

A

Combating Biofilm formation
Ab discovery
De novo drug designing
Detection & monitoring

60
Q

What are 3 current applications of AI?

A

Interpretation of antimicrobial susceptibility profiles - neural-network based app
In silico drug design approaches for structure & ligand based design
Virtual screening of drug candidates